clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Update Preferences
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Informatics
Alto Neuroscience Gets One Step Closer to Precision Depression Treatment
News & Features
Seattle Children’s CAR T Spinout BrainChild Bio Launches with a Focus…
News & Features
Texas Children’s Hospital Delivers First Gene Therapy for Rett Syndrome
News & Features
Separate Studies Show Why Some Prostate Cancers Become Resistant to Hormone…
Informatics
Generative AI Experts Absci Partner with AstraZeneca to Develop Cancer Treatment
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Virtual Event
Learning Labs
Podcasts
Inside Precision Medicine Live
Arthritis
Molecular Dx
Two Biomarkers Flag Heart Health Risk in Patients with Psoriatic Disease
Chris Anderson
-
March 9, 2022
0
Molecular Dx
U.K.’s Our Future Health Aims to Transform Disease Prevention, Detection, Treatment
Chris Anderson
-
January 20, 2022
0
News & Features
Mystery Behind Protein That Helps Some Cancers Progress but Not Others Solved
Helen Albert
-
January 5, 2022
0
News & Features
New Biosensors Precisely Monitor Drug Levels in Serum
Malorye Branca
-
December 20, 2021
0
News & Features
Feinstein Researchers ID New Therapeutic Target for Inflammatory Diseases and Neuropathic Pain
Anjali A. Sarkar, PhD
-
August 17, 2021
0
Molecular Dx
Novel Biomarker Could Aid Development of Drugs for Age-Related Disorders
Sophia Ktori
-
April 5, 2021
0
News & Features
Open Targets Initiative Finds DNA Variations Underlying Immune Diseases
Malorye Branca
-
September 23, 2019
0
News & Features
Oral Microbiome Biomarkers Show Potential for Arthritis Screening
Clinical OMICs Staff Writer
-
November 23, 2018
0
Molecular Dx
Genetic Biomarker Search Could Personalize Medicine for Arthritis Sufferers
Clinical OMICs Staff Writer
-
May 20, 2016
0
Related Content
Smartwatch Data Plus Digital Twin Framework Predicts Risk of Heart Disease and Heart Attack
Personalized Strategies Can Improve Dementia Risk
Basics of Cancer Care Lacking at Hospitals Serving Black and Hispanic Patients
Lowering Brain Cholesterol Shows Potential in Reducing Alzheimer’s-Like Damage in Mice
Inside Precision Medicine
![Epic Sciences said today its liquid biopsy blood test showed in a study that it can help physicians select prostate cancer patients who are likely to benefit from a Pfizer prostate-specific membrane antigen (PSMA)-targeted therapy candidate known as BIND-014 before the start of treatment. [Source: © Alex Tihonov/Fotolia]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1907.jpeg "Novel Biomarker Could Aid Development of Drugs for Age-Related Disorders")
